This document provides an overview of immunomodulators, which are drugs that modulate the immune system by either suppressing or stimulating it. It discusses the components of the immune system and classifies immunomodulators into immunosuppressants and immunostimulants. Examples of immunosuppressants discussed include corticosteroids like prednisolone, antimetabolites like methotrexate, antibiotics like cyclosporine. Their mechanisms of action and uses for suppressing the immune system, such as for organ transplants, are described. Immunostimulants are also briefly introduced as substances that can activate or increase immune system activity.
This 9-slide slide set created with PowerPoint is a short introduction to corticosteroids, in particular, the glucocorticoids, describing their receptor-mediated effects as well as why they exert both wanted and unwanted effects when used as anti-inflammatory and immunosuppressant drugs. This introduction to the topic of corticosteroids would be appropriate for beginners. Contributed by Christopher Fowler, Umeå University, Sweden.
Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogues of these hormones
The best use of systemic corticosteroids in the intensive care units, reviewMuhammad Asim Rana
Corticosteroids are one of the most common medications that are used in the intensive care units (ICUs);
corticosteroids are used for a variety of indications, including septic shock, acute respiratory distress syndrome
(ARDS), bacterial meningitis, tuberculous meningitis, lupus nephritis, severe chronic obstructive pulmonary disease
(COPD) exacerbations and many others.
Corticosteroids are associated with many severe side effects that affect morbidity and mortality of the patients like
increased risk of infections, glucose intolerance, hypokalemia, sodium retention, edema, hypertension, myopathy
etc. In order to make the best use of these medications and to minimize the unwanted side effects we should follow
some particular protocol. Please keep in our mind that there is controversy about dosing and tapering of steroids, so
effort has been made to include the best available evidence.
This review discusses mainly the most common indications of corticosteroids in ICU, dosing of corticosteroids in
those indications and how to taper corticosteroids according to the best evidence that recommends their use.
Literature search was done using Medline, BMJ, Uptodate, Chochrane database, Google scholar and the best
evidence based guidelines in which steroids are recommended to treat ICU related disorders. Sex hormones are not
discussed in this review since its use is rare in the intensive care units.
This 9-slide slide set created with PowerPoint is a short introduction to corticosteroids, in particular, the glucocorticoids, describing their receptor-mediated effects as well as why they exert both wanted and unwanted effects when used as anti-inflammatory and immunosuppressant drugs. This introduction to the topic of corticosteroids would be appropriate for beginners. Contributed by Christopher Fowler, Umeå University, Sweden.
Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogues of these hormones
The best use of systemic corticosteroids in the intensive care units, reviewMuhammad Asim Rana
Corticosteroids are one of the most common medications that are used in the intensive care units (ICUs);
corticosteroids are used for a variety of indications, including septic shock, acute respiratory distress syndrome
(ARDS), bacterial meningitis, tuberculous meningitis, lupus nephritis, severe chronic obstructive pulmonary disease
(COPD) exacerbations and many others.
Corticosteroids are associated with many severe side effects that affect morbidity and mortality of the patients like
increased risk of infections, glucose intolerance, hypokalemia, sodium retention, edema, hypertension, myopathy
etc. In order to make the best use of these medications and to minimize the unwanted side effects we should follow
some particular protocol. Please keep in our mind that there is controversy about dosing and tapering of steroids, so
effort has been made to include the best available evidence.
This review discusses mainly the most common indications of corticosteroids in ICU, dosing of corticosteroids in
those indications and how to taper corticosteroids according to the best evidence that recommends their use.
Literature search was done using Medline, BMJ, Uptodate, Chochrane database, Google scholar and the best
evidence based guidelines in which steroids are recommended to treat ICU related disorders. Sex hormones are not
discussed in this review since its use is rare in the intensive care units.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
Toxic effects of heavy metals : Lead and Arsenicsanjana502982
Heavy metals are naturally occuring metallic chemical elements that have relatively high density, and are toxic at even low concentrations. All toxic metals are termed as heavy metals irrespective of their atomic mass and density, eg. arsenic, lead, mercury, cadmium, thallium, chromium, etc.
This presentation explores a brief idea about the structural and functional attributes of nucleotides, the structure and function of genetic materials along with the impact of UV rays and pH upon them.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Richard's aventures in two entangled wonderlandsRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Sérgio Sacani
Since volcanic activity was first discovered on Io from Voyager images in 1979, changes
on Io’s surface have been monitored from both spacecraft and ground-based telescopes.
Here, we present the highest spatial resolution images of Io ever obtained from a groundbased telescope. These images, acquired by the SHARK-VIS instrument on the Large
Binocular Telescope, show evidence of a major resurfacing event on Io’s trailing hemisphere. When compared to the most recent spacecraft images, the SHARK-VIS images
show that a plume deposit from a powerful eruption at Pillan Patera has covered part
of the long-lived Pele plume deposit. Although this type of resurfacing event may be common on Io, few have been detected due to the rarity of spacecraft visits and the previously low spatial resolution available from Earth-based telescopes. The SHARK-VIS instrument ushers in a new era of high resolution imaging of Io’s surface using adaptive
optics at visible wavelengths.
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
1. Immunomodulators
Prepared By :-
Arjun S. Dhawale
[Student of B Pharm 4thyear 2018-2019]
Under the guidance of :-
Prof. Pravin Khatale
[M.Pharm ;Prof . S.G.S.P.S IOP, Akola]
1
3. Introduction:-
The immune system constitutes the body’s defense
against infectious agents. It protects the host by identifying and
eliminating or neutralizing agents that are recognized as nonself. The
entire range of immunological responses affects essentially every
organ, tissue, and cell of the body.
Immune responses include, in part, antibody (Ab)
production, allergy, inflammation, phagocytosis, cytotoxicity,
transplant and tumor rejection .
Types of Immunity:-
1) Active Immunity .
2) Passive Immunity .
3
4. 1)Active Immunity :-
It can be imparted either naturally by means of a clinical or
subclinical infection or artificially by injection of
appropriate antigen in the form of vaccine or toxides.
These vaccine contains the microbials strains of abnormaly
low pathogenicity.
Their administration lead to antiginic stimulus are
formation of antibodies at much faster rate. This type of
immunity normaly long lasting.
4
5. 2) Passive Immunity:-
This type of Immunity can be imparted either naturally by
placental transfer of mother to antibodies to her child.
Passive immunity offers protection immidietly but such a
protection is short duration.
5
6. Components Of Immunity:-
1) Lymphocytes
2) Cellular Immunity
3) Humoral Immunity
a) Immunoglobulin G
b) Immunoglobulin A
c) Immunoglobulin M
d) Immunoglobulin D
e) Immunoglobulin E
4) Immunoglobulin (Antibiotics)
5) Lymph nodes
6) Spleen
7) Thymus 6
7. Immunomodulators:-
Defn: These are the drugs or agents which either stimulant
or suppressant effect on immune system.
They are categorised as:-
1) Immunosuppressant.
2) Immunoenhancer.
7
11. SAR of Corticosteroids
1)Substituents of 1- dehydro 6 α - fluro increases anti-
inflammatory and glucocorticoid activity.
2)Substituents of 16 α - hydroxy, 16 α & 16 β-methyl & 17
ketol decrease the mineralocorticoid activity.
3)9 alpha - fluro, 21- hydroxy, 2 α - methyl and 9 α chloro
increases both glucocorticoids and mineralocorticoid
activity
11
12. Mechanism of Action
>These drugs reduce the increased
permeability of capillaries.
>They inhibit the leakage of inflammation producing
tissues by stabilizing the lysosomal membrane.
>The reduced permeability of capillaries inhibits the
migration of white cells out of blood stream, which in turn
decreases the number of such cell able to permit leakage
of their lysosomal enzymes into surrounding tissues.
12
14. Uses :-
1] It is use in treatment of autoimmune disorders
eg. rheumatic arthritis .
2] It increase the immunosuppressant activity.
14
15. Antimetabolites :-
These are the chemical agents which blocks the
action of metabolites or prevents its assimilation by
an organisms.
Drugs:
1) Azathioprine
2) Methotrexate
3) 6- mercaptopurine
4) Cytarabine
15
17. Mechanism of action Methotrexate :-
1]Inhibition of cell replication may be the key therapeutic
mechanism of methotrexate in neoplastic conditions.
2]It is the orally active folic acid analog having
antineoplastic mild immunosuppressant activity.
3]It acts by metabolism and affects the phase 11 of the
immune responses.
4]It does not block the expression of established delayed
hypersensitivity reaction but my alter the intensity of these
reactions.
17
19. Uses :-
1] Treatment of severe psoriasis.
2] In organ transplantation procedure.
3] As Anti-inflammatory.
19
20. Anti Biotics :-
Defn:-An antibiotic also called an antibacterial, is a type of antimicrobial
drugs used in the treatment and prevention of bacterial infections. They may either
kill or inhibit the growth of bacteria.
Eg:- Cyclosporine
20
22. Mechanism of action :-
1]Antigen stimulate the T-cell receptor (TCR) Lead to
generation of inositol triphosphate (IP3) increases in
calcium and formation of an activated calcineurin.
2] Calcineurin is a phosphate which dephosphorylates the
phosphorylated transcriptase factor for nuclear factor of
activated T-cell(NF-AT),allowing NF-AT to translocate to
the nucleolus to induce expression of cytokines genes.
3]Cyclosporine C bind to immunophilines to block the
phosphatase action of calciurine & prevent the expression
of cytokine gene induced by NF-AT.
22
25. Uses :-
1]It is use along with Glucocorticoid for
prophylaxis and treatment of organ, bone marrow
and heart transplantation.
2]It is use in the treatment of autoimmune diseases
like rheumatic arthritis.
25
27. Immunostimulants :-
Immunostimulants, are substances that stimulate
the immune system by inducing activation or increasing
activity of any of its components.
Classification :-
1] Specific .
2] Non – specific .
27
29. Reference :-
1]Principle medicinal chemistry by Dr.Kadam, Dr.
Mahadik & Dr. Bothara nirali prakashan volume Pg. no.
18.1 to 18.8 .
2]Book of Medicinal chemistry by Wilson & Gisvold
Pg.no156 to 178 .
3] Immunomodulatory by Arthur & David .
4] Immunostimulants: Types and Functions Sepideh Shahbazi,
Azam Bolhassani Department of Hepatitis and AIDS, Pasteur
Institute of Iran, Tehran, Iran.
5] Immunomodulatory drugs: Oral and systemic adverse effects
Antonio Bascones-Martinez , Riikka Mattila , Rafael Gomez-Font ,
Jukka H. Meurman .
29